GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PetIQ Inc (STU:39L) » Definitions » Ending Cash Position

PetIQ (STU:39L) Ending Cash Position : €23 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is PetIQ Ending Cash Position?

PetIQ's Ending Cash Position for the quarter that ended in Mar. 2024 was €23 Mil.

PetIQ's quarterly Ending Cash Position declined from Sep. 2023 (€117 Mil) to Dec. 2023 (€107 Mil) and declined from Dec. 2023 (€107 Mil) to Mar. 2024 (€23 Mil).

PetIQ's annual Ending Cash Position increased from Dec. 2021 (€70 Mil) to Dec. 2022 (€96 Mil) and increased from Dec. 2022 (€96 Mil) to Dec. 2023 (€107 Mil).


PetIQ Ending Cash Position Historical Data

The historical data trend for PetIQ's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetIQ Ending Cash Position Chart

PetIQ Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 24.55 27.50 70.27 95.59 106.71

PetIQ Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.73 72.40 116.76 106.71 23.34

PetIQ Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PetIQ's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=92.859+13.851
=107

PetIQ's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=107.059+-83.715
=23


PetIQ Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PetIQ's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


PetIQ (STU:39L) Business Description

Traded in Other Exchanges
Address
230 East Riverside Drive, Eagle, ID, USA, 83616
PetIQ Inc is a manufacturer and distributor of health and wellness products for dogs and cats. The company offers veterinarian-grade pet Rx medications, OTC flea and tick preventatives, vitamins treats, nutritional supplements, and hygiene products. The group operates in two segments namely the Products and Services segments. It also provides third-party products to retailers which for a long time were primarily available from veterinary clinics only. Its proprietary brands include PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, TruProfen, Betsy Farms, PetAction, Minties, Vera and Delightibles. The company generates maximum revenue from Products segment.

PetIQ (STU:39L) Headlines

No Headlines